The global assisted reproductive technology market size is expected to reach USD 54.75 Billion at a steady revenue CAGR of 9.7% in 2028, according to latest analysis by Emergen Research. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe. The report emphasizes the demands and ongoing trends of the global Assistive Reproductive Technology market, more importantly, across the major regions of the market. Assisted Reproductive Technology (ART) market revenue growth is driven by increasing popularity of In-Vitro Fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination, among other technologies.
Additionally, our analysts have included SWOT analysis and Porter’s Five Forces analysis in the report to offer a better understanding of the competitive spectrum of this ever-evolving industry. Infertility is a multi-faceted issue involving social, cultural, and economic implications, which may reach threatening extents in countries reporting lower fertility rates. According to statistics published by WHO, around 48 million couples and 186 million individuals live with infertility globally.
Growing incidence of ovulation problems with irregular or no periods is a common cause of infertility in women. Increased awareness pertaining to various fertility treatments among younger generation and more women opting for such fertility treatments is driving growth of the market. There is a higher prevalence of infertility among the male population across the globe. Rising stress levels, shift towards sedentary lifestyle, and increasing incidence of obesity is resulting in fertility issues, which is propelling growth of the assisted reproductive technology market.
To get a sample copy of the Global Assistive Reproductive Technology Market report, visit @ https://www.emergenresearch.com/request-sample/165
Some Key Highlights From the Report
- Frozen non-donor segment revenue is expected to register a significantly rapid growth rate during the forecast period due to their established reliability and a higher success rate for pregnancy. The procedure cost is lower as compared to cycles that use fresh embryos and eggs. A frozen transfer is much simpler for both reproductive endocrinologist and patient. This procedure is also less mentally and physically stressful on a women’s body.
- In June 2020, Ferring Pharmaceuticals announced a two-year collaboration with Igenomix for researching innovative disease mechanisms and targets discovery in conditions associated with infertility and pregnancy, such as preeclampsia, for developing groundbreaking diagnostic and therapeutic approaches for catering high unmet demand. A new hub in Boston was created which will bring experts from both companies and the focus is to investigate molecular structures, develop functional genomic systems and create tools to study embryo implantation among others.
The global Assistive Reproductive Technology market consists of various segments, including product type outlook, application spectrum, end-user overview, leading regions, and the competitive analysis. The report further provides information regarding the value chain, emerging market sectors, and the technological advancements in the industry to benefit readers and businesses looking to invest in this industry.
Key Market Competitors Profiled in the Report:
- Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd.
A significant cause of infertility among the global population is Sexually Transmitted Diseases (STDs), predominantly gonorrhea, and chlamydia. These diseases can cause damage or scarring of the fallopian tubes in women and blockage and scarring of the reproductive structures (e.g., ejaculatory ducts), resulting in infertility. However, assisted reproductive technology procedures are expensive and most people in developing countries cannot afford it. Moreover, social stigma regarding such procedures is also hampering market revenue growth.
To learn more details about the Global Assistive Reproductive Technology Market report, visit @ https://www.emergenresearch.com/industry-report/assisted-reproductive-technology-market
The latest report offers a profound analysis of the present market scenario, its key product types, end-user landscape, application outlook, leading regions, competitive terrain, and the leading companies’ detailed profiles. The study performs a historical assessment of the Assistive Reproductive Technology from 2017 to 2018, focusing on the market trends, revenue share, growth rate, production capacity, pricing structure, and other vital aspects during that period. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.
Emergen Research has segmented the global assisted reproductive technology market on the basis of procedure, technology, end-use, and region:
- Procedure Outlook (Revenue, USD Billion; 2018-2028)
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
- Egg/Embryo Banking
- Technology Outlook (Revenue, USD Billion; 2018-2028)
- In-Vitro Fertilization (IVF)
- In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
- In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination
- Frozen Embryo Transfer (FET)
- Others
- End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals
- Fertility Clinics
- Others
The global Assistive Reproductive Technology market report evaluates the latest economic scenario in terms of value and volume. It highlights the key growth drivers, restraints, production capacity, demand & supply ratio, import/export status, growth rate, and other critical aspects. Additionally, the report also performs SWOT analysis, Porter’s Five Forces analysis, speculation attainability investigation, and venture return investigation.
Global Assistive Reproductive Technology Market Geographical Landscape – Synopsis:
- The report closely studies the growth trajectory of the global Assistive Reproductive Technology market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
- The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
- Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.
Proceed To Buy: https://www.emergenresearch.com/select-license/165
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028
Chapter 3. Key Insights
Chapter 4. Assisted Reproductive Technology Market Segmentation & Impact Analysis
4.1. Assisted Reproductive Technology Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing prevalence of ovulation problem
4.2.2.2. Growing awareness and social adoption of assisted reproductive technology
4.2.2.3. Surge in infertility rate
4.2.2.4. Rising number of single women
4.2.3. Market restraints analysis
4.2.3.1. Stringent regulatory norms
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Assisted Reproductive Technology Market By Procedure Insights & Trends, Revenue (USD Billion)
5.1. Procedure Dynamics & Market Share, 2021& 2028
5.1.1. Fresh Donor
5.1.2. Fresh Non-Donor
5.1.3. Frozen Donor
5.1.4. Frozen Non-Donor
5.1.5. Egg/Embryo Banking
Continue…
Key Objectives of the Report:
- Analysis and estimation of the Assistive Reproductive Technology market size and share for the projected period of 2020-2027
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Assistive Reproductive Technology market
Global Assistive Reproductive Technology Market Highlights:
- Regional demand estimation and forecast
- Product Mix Matrix
- R&D Analysis
- Cost-Benefit Analysis
- Pre-commodity pricing volatility
- Supply chain optimization analysis
To get a discount on the Global Assistive Reproductive Technology Market report, visit @ https://www.emergenresearch.com/request-discount/165
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Read similar reports by Emergen Research:
RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market
Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market
Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Molecular Diagnostics Point of Care Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
